<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d73">
    <sentence id="DDI-DrugBank.d73.s0" text="Catecholamine-depleting drugs (eg, reserpine) may have an additive effect when given with beta-blocking agents.">
        <entity charOffset="35-43" id="DDI-DrugBank.d73.s0.e0" text="reserpine" type="drug"/>
        <entity charOffset="90-108" id="DDI-DrugBank.d73.s0.e1" text="beta-blocking agent" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d73.s0.e0" e2="DDI-DrugBank.d73.s0.e1" id="DDI-DrugBank.d73.s0.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s1" text="Patients treated with TENORMIN plus a catecholamine depletor should therefore be closely observed for evidence of hypotension and/or marked bradycardia which may produce vertigo, syncope, or postural hypotension.">
        <entity charOffset="22-29" id="DDI-DrugBank.d73.s1.e0" text="TENORMIN" type="brand"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s2" text="Calcium channel blockers may also have an additive effect when given with TENORMIN .">
        <entity charOffset="0-23" id="DDI-DrugBank.d73.s2.e0" text="Calcium channel blockers" type="group"/>
        <entity charOffset="74-81" id="DDI-DrugBank.d73.s2.e1" text="TENORMIN" type="brand"/>
        <pair ddi="true" e1="DDI-DrugBank.d73.s2.e0" e2="DDI-DrugBank.d73.s2.e1" id="DDI-DrugBank.d73.s2.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s3" text="Beta blockers may exacerbate the rebound hypertension which can follow the withdrawal of clonidine.">
        <entity charOffset="0-12" id="DDI-DrugBank.d73.s3.e0" text="Beta blockers" type="group"/>
        <entity charOffset="89-97" id="DDI-DrugBank.d73.s3.e1" text="clonidine" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d73.s3.e0" e2="DDI-DrugBank.d73.s3.e1" id="DDI-DrugBank.d73.s3.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s4" text="If the two drugs are coadministered, the beta blocker should be withdrawn several days before the gradual withdrawal of clonidine.">
        <entity charOffset="41-52" id="DDI-DrugBank.d73.s4.e0" text="beta blocker" type="group"/>
        <entity charOffset="120-128" id="DDI-DrugBank.d73.s4.e1" text="clonidine" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d73.s4.e0" e2="DDI-DrugBank.d73.s4.e1" id="DDI-DrugBank.d73.s4.p0" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s5" text="If replacing clonidine by beta-blocker therapy, the introduction of beta blockers should be delayed for several days after clonidine administration has stopped.">
        <entity charOffset="13-21" id="DDI-DrugBank.d73.s5.e0" text="clonidine" type="drug"/>
        <entity charOffset="26-37" id="DDI-DrugBank.d73.s5.e1" text="beta-blocker" type="group"/>
        <entity charOffset="68-80" id="DDI-DrugBank.d73.s5.e2" text="beta blockers" type="group"/>
        <entity charOffset="123-131" id="DDI-DrugBank.d73.s5.e3" text="clonidine" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d73.s5.e0" e2="DDI-DrugBank.d73.s5.e1" id="DDI-DrugBank.d73.s5.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d73.s5.e0" e2="DDI-DrugBank.d73.s5.e2" id="DDI-DrugBank.d73.s5.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d73.s5.e0" e2="DDI-DrugBank.d73.s5.e3" id="DDI-DrugBank.d73.s5.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d73.s5.e1" e2="DDI-DrugBank.d73.s5.e2" id="DDI-DrugBank.d73.s5.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d73.s5.e1" e2="DDI-DrugBank.d73.s5.e3" id="DDI-DrugBank.d73.s5.p4"/>
        <pair ddi="true" e1="DDI-DrugBank.d73.s5.e2" e2="DDI-DrugBank.d73.s5.e3" id="DDI-DrugBank.d73.s5.p5" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s6" text="Concomitant use of prostaglandin synthase inhibiting drugs, eg, indomethacin, may decrease the hypotensive effects of beta blockers.">
        <entity charOffset="64-75" id="DDI-DrugBank.d73.s6.e0" text="indomethacin" type="drug"/>
        <entity charOffset="118-130" id="DDI-DrugBank.d73.s6.e1" text="beta blockers" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d73.s6.e0" e2="DDI-DrugBank.d73.s6.e1" id="DDI-DrugBank.d73.s6.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s7" text="Information on concurrent usage of atenolol and aspirin is limited.">
        <entity charOffset="35-42" id="DDI-DrugBank.d73.s7.e0" text="atenolol" type="drug"/>
        <entity charOffset="48-54" id="DDI-DrugBank.d73.s7.e1" text="aspirin" type="brand"/>
        <pair ddi="false" e1="DDI-DrugBank.d73.s7.e0" e2="DDI-DrugBank.d73.s7.e1" id="DDI-DrugBank.d73.s7.p0"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s8" text="Data from several studies, ie, TIMI-II, ISIS-2, currently do not suggest any clinical interaction between aspirin and beta blockers in the acute myocardial infarction setting.">
        <entity charOffset="106-112" id="DDI-DrugBank.d73.s8.e0" text="aspirin" type="brand"/>
        <entity charOffset="118-130" id="DDI-DrugBank.d73.s8.e1" text="beta blockers" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d73.s8.e0" e2="DDI-DrugBank.d73.s8.e1" id="DDI-DrugBank.d73.s8.p0"/>
    <negationtags>Data from several studies, ie, TIMI-II, ISIS-2, currently do &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; suggest any clinical interaction between aspirin and beta blockers in the acute myocardial infarction setting. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d73.s9" text="While taking beta blockers, patients with a history of anaphylactic reaction to a variety of allergens may have a more severe reaction on repeated challenge, either accidental, diagnostic or therapeutic.">
        <entity charOffset="13-25" id="DDI-DrugBank.d73.s9.e0" text="beta blockers" type="group"/>
    </sentence>
    <sentence id="DDI-DrugBank.d73.s10" text="Such patients may be unresponsive to the usual doses of epinephrine used to treat the allergic reaction.">
        <entity charOffset="56-66" id="DDI-DrugBank.d73.s10.e0" text="epinephrine" type="drug"/>
    </sentence>
</document>